Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,310,361
in 7 filings, $252K under 10b5-1 plans

Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-07-10 GUALBERTO ANTONIO Head of Development & CMO Exercise or conversion +18,000 $6.15 $111K 357,973
2019-07-10 GUALBERTO ANTONIO Head of Development & CMO Sale −18,000 $21.11 $380K 339,973
2019-07-10 GUALBERTO ANTONIO Head of Development & CMO Exercise or conversion · Option to purchase common stock −18,000 151,000
2019-01-22 GUALBERTO ANTONIO Head of Development & CMO Grant or award · Option to purchase common stock +140,000 140,000

Page 1 of 1 · 4 trades